PubRank
Search
About
Andreas Stengel
Author PubWeight™ 27.98
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Somatic comorbidities of irritable bowel syndrome: a systematic analysis.
J Psychosom Res
2008
1.54
2
Bombesin, but not amylin, blocks the orexigenic effect of peripheral ghrelin.
Am J Physiol Regul Integr Comp Physiol
2006
1.47
3
Nesfatin-1 immunoreactivity in rat brain and spinal cord autonomic nuclei.
Neurosci Lett
2009
1.21
4
Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats.
Peptides
2008
1.14
5
Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats.
Brain Res
2009
1.14
6
CCK inhibits the orexigenic effect of peripheral ghrelin.
Am J Physiol Regul Integr Comp Physiol
2004
1.07
7
The importance of using the optimal plasticware and glassware in studies involving peptides.
Anal Biochem
2011
1.05
8
CCK-8S activates c-Fos in a dose-dependent manner in nesfatin-1 immunoreactive neurons in the paraventricular nucleus of the hypothalamus and in the nucleus of the solitary tract of the brainstem.
Regul Pept
2009
1.00
9
A role for corticotropin-releasing factor in functional gastrointestinal disorders.
Curr Gastroenterol Rep
2009
0.97
10
Localization of nesfatin-1 neurons in the mouse brain and functional implication.
Brain Res
2011
0.97
11
Novel insight in distribution of nesfatin-1 and phospho-mTOR in the arcuate nucleus of the hypothalamus of rats.
Peptides
2009
0.96
12
Central nesfatin-1 reduces the nocturnal food intake in mice by reducing meal size and increasing inter-meal intervals.
Peptides
2010
0.94
13
Peripheral activation of corticotropin-releasing factor receptor 2 inhibits food intake and alters meal structures in mice.
Peptides
2010
0.90
14
Peripheral injection of ghrelin induces Fos expression in the dorsomedial hypothalamic nucleus in rats.
Brain Res
2008
0.89
15
Peripheral injection of CCK-8S induces Fos expression in the dorsomedial hypothalamic nucleus in rats.
Brain Res
2006
0.88
16
Pattern of Fos expression in the brain induced by selective activation of somatostatin receptor 2 in rats.
Brain Res
2010
0.86
17
Comparison of CRF-immunoreactive neurons distribution in mouse and rat brains and selective induction of Fos in rat hypothalamic CRF neurons by abdominal surgery.
Brain Res
2011
0.86
18
Mice overexpressing corticotropin-releasing factor show brain atrophy and motor dysfunctions.
Neurosci Lett
2010
0.84
19
Irisin: what promise does it hold?
Curr Opin Clin Nutr Metab Care
2013
0.84
20
Intravenous injection of urocortin 1 induces a CRF2 mediated increase in circulating ghrelin and glucose levels through distinct mechanisms in rats.
Peptides
2012
0.83
21
Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents.
Peptides
2008
0.82
22
NUCB2/nesfatin-1 is associated with elevated scores of anxiety in female obese patients.
Psychoneuroendocrinology
2013
0.81
23
The ghrelin activating enzyme ghrelin-O-acyltransferase (GOAT) is present in human plasma and expressed dependent on body mass index.
Peptides
2013
0.81
24
Subjective theories of illness and clinical and psychological outcomes in patients with irritable bowel syndrome.
J Psychosom Res
2009
0.81
25
Orexigenic response to tail pinch: role of brain NPY(1) and corticotropin releasing factor receptors.
Am J Physiol Regul Integr Comp Physiol
2013
0.80
26
Lipopolysaccharide increases plasma levels of corticotropin-releasing hormone in rats.
Neuroendocrinology
2010
0.79
27
CCK-8 and CCK-58 differ in their effects on nocturnal solid meal pattern in undisturbed rats.
Am J Physiol Regul Integr Comp Physiol
2012
0.77
28
The CCKB antagonist CI988 reduces food intake in fasted rats via a dopamine mediated pathway.
Peptides
2012
0.76
29
Editorial: As the field of ghrelin is moving forward toward translational applications, expert reviews on the multiple ghrelin actions may provide a broader overview of the relevance of this peptide as well as pointing toward research gaps to be filled.
Peptides
2011
0.75
30
New developments on NUCB2/nesfatin-1.
Curr Pharm Des
2013
0.75
31
[Psychotherapy in Times of the Covid-19 Pandemic - A Brief Reflection].
Psychother Psychosom Med Psychol
2020
0.75